
Capricor Therapeutics CAPR
$ 27.53
-1.29%
Quarterly report 2025-Q3
added 11-10-2025
Capricor Therapeutics DSO Ratio 2011-2026 | CAPR
Annual DSO Ratio Capricor Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 31.9 | 44.7 | 47.2 | 20.4 | 14 | 27.5 | 0.136 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 47.2 | 0.136 | 26.6 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Ascendis Pharma A/S
ASND
|
132 | $ 232.12 | 1.37 % | $ 5 B | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.47 | -1.73 % | $ 8.35 B | ||
|
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
ADMA Biologics
ADMA
|
74.6 | $ 15.38 | 1.32 % | $ 3.67 B | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
60.7 | $ 16.0 | -2.79 % | $ 2.43 B | ||
|
Adverum Biotechnologies
ADVM
|
222 | - | - | $ 86.2 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
Alkermes plc
ALKS
|
88.9 | $ 30.02 | -2.31 % | $ 4.94 B | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
70.9 | $ 20.19 | -23.78 % | $ 944 M | ||
|
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Aurinia Pharmaceuticals
AUPH
|
185 | $ 14.1 | 0.89 % | $ 1.89 B | ||
|
Athersys
ATHX
|
22.6 | - | 3.77 % | $ 22.4 M | ||
|
Axsome Therapeutics
AXSM
|
105 | $ 163.5 | 0.19 % | $ 8.13 B | ||
|
Aytu BioScience
AYTU
|
150 | $ 2.57 | 4.47 % | $ 16.1 M |